Shopping Cart 0
Cart Subtotal
USD 0

Evgen Pharma Plc (EVG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company that develops clinical pipeline for breast cancer and subarachnoid haemorrhage. The company develops SFX-01 to reduce the vasospasm and incidence of delayed cerebral ischemia which leads to cognitive impairment. Its clinical pipeline product is based on proprietary Sulforadex platform technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. Evgen Pharma carries out preclinical work in multiple sclerosis and has clinical interest in prostate cancer. The company also conducts clinical trials in oncology in patients with ER+ metastatic breast cancer. It has operations in Wilmslow, Liverpool and London, the UK. Evgen Pharma is headquartered in Wilmslow, the UK.

Evgen Pharma Plc (EVG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Evgen Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Evgen Pharma Raises USD3.1 Million Financing 10

Evgen Raises USD 0.72 Million In Series B Financing 11

Partnerships 12

Evgen Pharma Enters into Agreement with Imperial College London 12

Evgen Pharma Enters into Agreement with King's College London 13

Licensing Agreements 14

Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 14

Equity Offering 15

Evgen Pharma Raises USD1 Million in Private Placement of Shares 15

Evgen Pharma Raises USD11 Million in IPO 16

Evgen Pharma Plc-Key Competitors 17

Evgen Pharma Plc-Key Employees 18

Evgen Pharma Plc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Financial Announcements 20

Jun 13, 2018: Evgen Pharma: Final Results for the year ended 31 March 2018 20

Dec 08, 2017: Evgen Pharma: Interim results for the six months ended 30 September 2017 21

Jun 13, 2017: Evgen Pharma Announces Final Results for the year ended 31 March 2017 22

Corporate Communications 23

Apr 03, 2017: Evgen Pharma Announces Directorate Change 23

Jan 17, 2017: Evgen Pharma: Appointment of CFO and Head of Clinical Operations 24

Product News 25

08/02/2017: Evgen Pharma: SFX-01 data published in Peer Reviewed Journal 25

Clinical Trials 26

Jun 11, 2018: Evgen Pharma: Interim update on STEM trial 26

Apr 24, 2018: Evgen Pharma Announces Presentation at World Orphan Drug Congress USA 28

Mar 05, 2018: Evgen Pharma: Update on novel sulforaphane analogues 29

Jan 15, 2018: Evgen Pharma: Poster presentation of SFX-01 stem cell data in breast cancer 30

Dec 11, 2017: Hardman Research: Funded to the end of Phase II trials 31

Oct 04, 2017: Evgen Pharma: First European Patent Grant 32

Jul 11, 2017: Evgen Pharma: Charity-funded Study of SFX-01 in Triple Negative Breast Cancer 33

Jan 17, 2017: Evgen Pharma Announces First Patient Dosed in Phase II Breast Cancer Trial 34

Jan 11, 2017: Evgen Pharma Receives Positive DSMB Review of SAS Trial 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Evgen Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Evgen Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 8

Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Evgen Pharma Raises USD3.1 Million Financing 10

Evgen Raises USD 0.72 Million In Series B Financing 11

Evgen Pharma Enters into Agreement with Imperial College London 12

Evgen Pharma Enters into Agreement with King's College London 13

Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 14

Evgen Pharma Raises USD1 Million in Private Placement of Shares 15

Evgen Pharma Raises USD11 Million in IPO 16

Evgen Pharma Plc, Key Competitors 17

Evgen Pharma Plc, Key Employees 18

Evgen Pharma Plc, Other Locations 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Evgen Pharma Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.